The company's Genedrive® system is suitable for use outside of traditional hospital settings and can rapidly analyze nucleic acids from fresh or stored samples to provide rapid diagnosis and decision making. The company operates in one operating segment named as Diagnostics and has an active development program underway for tuberculosis detection and drug resistance assessment. The company has launched several products, including the Genedrive MT-RNR1 ID Kit and the Genedrive COV19-ID Kit, which is a rapid point of care test for COVID-19.